Cognition Therapeutics Participating in Upcoming Investor Conferences
Cognition Therapeutics announced that CEO Lisa Ricciardi will present at two upcoming financial conferences in June. She will provide updates on the company’s plans for a registration program in DLB psychosis.
Key figures
- Grant funding
- $200 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.